Low Dose Ketamine as an Adjunct to Fentanyl in Outpatient Tonsillectomy
Brief Summary
Comparing patients receiving subanesthetic doses of Ketamine vs placebo to see if it can reduce narcotic needs for patients receiving a tonsillectomy and adenoidectomy
Intervention / Treatment
-
Ketamine (DRUG)Single IV dose of 0.1 mg/kg of ketamine
-
Placebo (DRUG)Saline given of equal volume to drug
Condition or Disease
- Pain
Phase
Study Design
| Study type: | INTERVENTIONAL |
|---|---|
| Status: | Completed |
| Study results: | No Results Available |
| Age: | 3 Years to 12 Years |
| Enrollment: | 122 (ACTUAL) |
| Funded by: | Other |
| Allocation: | Randomized |
| Primary Purpose: | Treatment |
Masking |
|
Clinical Trial Dates
| Start date: | Aug 01, 2006 | |
|---|---|---|
| Primary Completion: | Oct 01, 2007 | ACTUAL |
| Completion Date: | Dec 01, 2007 | ACTUAL |
| Study First Posted: | Jan 07, 2008 | ESTIMATED |
| Results First Posted: | Aug 31, 2020 | |
| Last Updated: | Jun 12, 2017 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Location
Eligibility Criteria
| Sex: | All |
|---|---|
| Minimum Age: | 3 |
| Maximum Age: | 12 |
| Healthy Volunteers: | Yes |
Inclusion Criteria:between 3 and 12 years of age
* ASA 1 or 2
Exclusion Criteria:
* did not consent
* ASA 1 or 2
Exclusion Criteria:
* did not consent
Primary Outcomes
-
amount of post op narcotic use 5 days
Secondary Outcomes
-
degree of nausea and vomiting 5 days
More Details
| NCT Number: | NCT00587665 |
|---|---|
| Other IDs: | 1896-05 |
| Study URL: | https://clinicaltrials.gov/study/NCT00587665 |
Last updated: Sep 29, 2023